|
Volumn 378, Issue 9809, 2011, Pages 2064-2065
|
In defence of our research on competition in England's National Health Service
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
FIBRINOLYTIC AGENT;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ACUTE HEART INFARCTION;
BLOOD CLOT LYSIS;
CLINICAL RESEARCH;
COMPETITION;
CONFLICT OF INTEREST;
EVIDENCE BASED PRACTICE;
HEALTH CARE POLICY;
HEALTH CARE QUALITY;
HOSPITAL DISCHARGE;
HUMAN;
LENGTH OF STAY;
LETTER;
MORTALITY;
NATIONAL HEALTH SERVICE;
OUTCOME ASSESSMENT;
PATIENT CARE;
PATIENT SATISFACTION;
PEER REVIEW;
PERCUTANEOUS CORONARY INTERVENTION;
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY;
POLITICS;
PRIORITY JOURNAL;
RISK FACTOR;
SCIENCE;
STATISTICAL ANALYSIS;
UNITED KINGDOM;
|
EID: 83955161233
PISSN: 01406736
EISSN: 1474547X
Source Type: Journal
DOI: 10.1016/S0140-6736(11)61708-X Document Type: Letter |
Times cited : (19)
|
References (12)
|